Une T, Satoh K, Tanaka N, Ogawa H
Arzneimittelforschung. 1978;28(9):1599-602.
Ascending pyelonephritis was successfully produced in rats by means of direct inoculation with a virulent strain of Escherichia coli into the bladder enclosing a glass ball. 3-Carbamoyloxymethyl-7-alpha-methoxy-7-[2(2-thienyl)-acetamido]-3-cephem-4-carboxylic acid (cefoxitin) or cefazolin as a control drug was applied to the affected rats characterized by purulent inflammation in pelvis and medulla sometimes accompanied with abscess formation in medulla and/or coretex 3 days after challenge. The treatments were performed at an i.v. dose of 40 mg/kg 3 times a day for 5 consecutive days. The improvement of the disease, that is disappearance of the bacilli in the kidney, improvement of BUN value and of histopathological findings in cefoxitin-treated animals was approximately equal to that in cefazolin-treated ones. Both antibiotics exhibited great effectiveness against purulent pyelonephritis, however, not sufficiently effective against medullar and cortical abscesses. Chemotherapeutic effect of cefoxitin on experimental pyelonephritis was discussed with special reference to its distribution into the affected tissues.
通过将毒力强的大肠杆菌菌株直接接种到包有玻璃球的膀胱中,成功地在大鼠身上诱发了上行性肾盂肾炎。在攻击后3天,对以肾盂和髓质脓性炎症为特征、有时伴有髓质和/或皮质脓肿形成的患病大鼠,应用3-氨甲酰氧基甲基-7-α-甲氧基-7-[2(2-噻吩基)-乙酰胺基]-3-头孢烯-4-羧酸(头孢西丁)或作为对照药物的头孢唑林。治疗以静脉注射剂量40mg/kg、每天3次、连续5天进行。头孢西丁治疗的动物疾病的改善,即肾脏中细菌的消失、血尿素氮值的改善和组织病理学结果的改善,与头孢唑林治疗的动物大致相同。两种抗生素对脓性肾盂肾炎均显示出巨大疗效,然而,对髓质和皮质脓肿的疗效并不充分。特别参考头孢西丁在受影响组织中的分布,讨论了其对实验性肾盂肾炎的化疗作用。